First MHRA/NICE aligned guidance due in June
The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.
Newsletters and Deep Dive digital magazine
The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.
New hospital-level analysis shows a provider landscape that is more concentrated, regionally uneven & strategically complex than commercially assumed.
Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.
A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.
BioMarin has suspended dosing in phase 2 trials of its achondroplasia therapy Voxzogo aimed at broadening the drug's label.
Editor's Picks
Newsletters and Deep Dive
digital magazine